SPTBN4 and MODY: Similarly, in the case of MODY diabetes, the heterozygous MLKL loss-of-function mutation also segregated with heterozygous deleterious mutations in the known MODY gene PDX1, as well as ERN2, NIPAL4 and SPTBN4 in affected individuals [47].